Effect of Mediterranean Diet and Physical Activity in Patients With Endometriosis
PHAMEDENDO
1 other identifier
interventional
140
1 country
1
Brief Summary
The main aim of this study is to evaluate whether a dietary recommendation based on the Mediterranean diet's principles associated with a regular aerobic physical activity, according to the "7 minutes workout", may improve pain symptoms in patients with symptomatic endometriosis (pelvic pain with numerical rating scale, NRS ≥ 4), in therapy with estrogen-progestins or progestins.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jan 2019
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 10, 2019
CompletedFirst Submitted
Initial submission to the registry
March 25, 2019
CompletedFirst Posted
Study publicly available on registry
June 21, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 20, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
November 20, 2023
CompletedJuly 9, 2025
June 1, 2025
1.5 years
March 25, 2019
July 4, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Pelvic pain changes in patients with endometriosis who follow a mediterranean diet and a regular physical activity
The presence and severity of dysmenorrhea, deep dyspareunia, and non-menstrual pelvic pain will be assessed using an 11-point numeric rating scale (NRS), with 0 indicating absence of pain and 10 pain as bad as it could be. Scores 1 to 4 will be considered mild pain, 5 to 7 moderate pain, and 8 to 10 severe pain. Patients will be considered for enrollment if they complained of at least moderate or severe pelvic pain (NRS score ≥ 4).
12 months
Secondary Outcomes (5)
The degree of satisfaction in patients with endometriosis who follow a mediterranean diet and a regular physical activity
12 months
Changes in state of anxiety and depression in patients with endometriosis who follow a mediterranean diet and a regular physical activity
12 months
Changes in sexual dysfunction and sexual satisfaction in patients with endometriosis who follow a mediterranean diet and a regular physical activity
12 months
Changes in quality of life in patients with endometriosis who follow a mediterranean diet and a regular physical activity.
12 months
Changes in global improvement over time in patients with endometriosis who follow a mediterranean diet and a regular physical activity.
12 months
Study Arms (2)
Intervention group
EXPERIMENTALpatients with symptomatic endometriosis in therapy with estro-progestins or progestins, who will be asked to follow a mediterranean diet and to practice an aerobic physical exercise according to the "7-minutes workout" model
Control group
NO INTERVENTIONpatients with symptomatic endometriosis in therapy with estro-progestins or progestins.
Interventions
follow a mediterranean diet and practice a regular aerobic exercise according to the "7-minutes workout" model.
Eligibility Criteria
You may qualify if:
- age between 18 and 45 years
- body mass index between 18 and 29.9
- women with symptomatic endometriosis (pelvic pain with NRS score ≥ 4), in therapy with estro-progestins or progestins
- not seeking conception
You may not qualify if:
- associated diseases that cause pelvic pain regardless of the presence of endometriosis, or chronic intestinal diseases (Crohn's disease or ulcerative rectocolitis).
- patients in note for all kind of surgery
- women who conduct a strong physical activity.
- women who follow vegetarian-vegan diet regimens.
- metabolic diseases that require specific dietary indications (diabetes and celiac disease, food allergies).
- medical contraindications to proposed physical activity.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Laura Buggio Centro Endometriosi e Metrorragie Clinica Mangiagalli, Fondazione IRCCS Cà Granda Ospedale Maggiore Policlinico
Milan, 20122, Italy
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 25, 2019
First Posted
June 21, 2019
Study Start
January 10, 2019
Primary Completion
July 20, 2020
Study Completion
November 20, 2023
Last Updated
July 9, 2025
Record last verified: 2025-06